William Hoffman - May 5, 2021 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Signature
/s/ Angela Ahmad, attorney-in-fact for William Hoffman
Stock symbol
NARI
Transactions as of
May 5, 2021
Transactions value $
-$3,075,893
Form type
4
Date filed
5/7/2021, 01:09 PM
Next filing
Jun 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale -$676K -6.7K -0.7% $100.82 945K May 5, 2021 Direct F1, F2
transaction NARI Common Stock Sale -$930K -9.17K -0.97% $101.40 935K May 5, 2021 Direct F1, F3
transaction NARI Common Stock Sale -$394K -3.85K -0.41% $102.52 931K May 5, 2021 Direct F1, F4
transaction NARI Common Stock Sale -$324K -3.12K -0.34% $103.81 928K May 5, 2021 Direct F1, F5
transaction NARI Common Stock Sale -$565K -5.39K -0.58% $104.75 923K May 5, 2021 Direct F1, F6
transaction NARI Common Stock Sale -$123K -1.17K -0.13% $105.58 922K May 5, 2021 Direct F1, F7
transaction NARI Common Stock Sale -$63.9K -600 -0.07% $106.45 921K May 5, 2021 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020
F2 This transaction was executed in multiple trades at prices ranging from $100.11 to $101.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $101.12 to $102.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $102.15 to $103.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $103.16 to $104.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $104.20 to $105.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $105.20 to $105.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8 This transaction was executed in multiple trades at prices ranging from $106.21 to $106.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.